Immunohistochemical Distinction of Primary Sweat Gland Carcinoma and Metastatic Breast Carcinoma
|
|
- Julianna Gardner
- 6 years ago
- Views:
Transcription
1 AJCP / Original Article Immunohistochemical Distinction of Primary Sweat Gland Carcinoma and Metastatic Breast Carcinoma Can It Always Be Accomplished Reliably? Mark J. Mentrikoski, MD, and Mark R. Wick, MD From the Division of Surgical Pathology and Cytopathology, University of Virginia Medical Center, Charlottesville. CME/SAM Key Words: Sweat gland carcinoma; Metastatic cutaneous breast carcinoma; Immunohistochemistry; Differential diagnosis Am J Clin Pathol March 2015;143: ABSTRACT Objectives: Even with adequate history, the distinction of cutaneous metastatic breast carcinoma from primary sweat gland carcinoma can be difficult. Although previous studies have attempted to separate these tumors with various immunohistochemical panels, those series have been limited by small numbers of patients as well as the inclusion of benign sweat gland tumors. Methods: In this analysis, stains for p63, CK5/6, and D2-40 were included, as well as GATA3 and mammaglobin, in an evaluation of 21 primary sweat gland carcinomas and 33 examples of cutaneous metastatic breast carcinoma. Results: Immunoreactivity for p63, CK5/6, D2-40, GATA3, and mammaglobin was respectively observed in 81%, 71%, 52%, 71%, and 5% of sweat gland carcinomas compared with 6%, 6%, 6%, 91%, and 45% of metastatic breast carcinomas. These differences were statistically significant for p63, CK5/6, and D2-40. For the diagnosis of metastatic breast carcinoma, GATA3 was the most sensitive marker (91%), but its sensitivity was substantially lower. Mammaglobin was 95% specific for breast carcinoma but again suffered from limited sensitivity (45%) in this context. Conclusions: These data suggest that p63 and CK5/6 are specific determinants for sweat gland carcinoma in the stated setting. In the absence of those analytes, metastatic breast carcinoma cannot always be identified to the exclusion of a primary tumor. This diagnostic scenario continues to require the procurement of a detailed clinical history regarding the number and duration of skin lesions in any given case. Upon completion of this activity you will be able to: list immunohistochemical stains that may be useful in distinguishing metastatic breast carcinoma from primary cutaneous adnexal carcinomas. discuss the importance of obtaining clinical information when evaluating cutaneous metastases. The ASCP is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The ASCP designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 Credit per article. Physicians should claim only the credit commensurate with the extent of their participation in the activity. This activity qualifies as an American Board of Pathology Maintenance of Certification Part II Self-Assessment Module. The authors of this article and the planning committee members and staff have no relevant financial relationships with commercial interests to disclose. Questions appear on p 461. Exam is located at Morphologic mimicry between two clinicopathologic entities can produce substantial diagnostic challenges. Indeed, that fact largely accounts for the important role that immunohistochemistry (IHC) currently plays in diagnostic anatomic pathology. One particular example of this phenomenon in dermatopathology is the microstructural similarity between metastatic ductal mammary carcinoma (MDMC) and primary cutaneous sweat gland carcinoma (SGC). Although metastasis of internal malignancies to the skin is relatively rare, it may occasionally be the first sign of systemic disease in patients with breast cancer. 1-3 Because both SGC and MDMC comprise cytologically atypical dermal nests of epithelioid cells, often containing duct-like structures, a distinction between those two tumor types can be virtually impossible on the basis of morphologic analysis alone. That fact is not surprising, because the breasts and the sweat glands are functional and structural homologues of 430 Am J Clin Pathol 2015;143:
2 AJCP / Original Article one another. Both of them derive from ectodermal appendages, and although the mammary ducts arise from specialized mammary ridges, they are essentially comparable to modified sweat glands. Therefore, MDMC and SGC can bear a striking resemblance to one another at histologic and immunohistochemical levels of analysis. In the past, clinical features such as the location and number of the neoplasms, a history of malignancy, and lesional duration have been stressed as important diagnostic determinants. When such information is lacking, ancillary studies such as IHC may be pursued, in hopes that they may lead to an accurate pathologic classification of the tumor in question. Over the past 2 decades, several studies have examined with variable success selected individual immunostains, or panels of them, to make the specified distinction Although SGC often labels for so-called basal cell markers such as p63 and cytokeratin (CK) 5/6, that is not always true. Moreover, a suitably sensitive, specific, and exclusive marker for MDMC has not yet emerged. Shortcomings have existed in prior studies that compared SGC and MDMC. The first problem relates to the rarity of malignant sweat gland neoplasms and limited numbers of those lesions that have been available for evaluation. In response to that drawback, some authors also have included morphologically benign appendageal neoplasms of the skin for comparison with MDMC a step that unquestionably distorts the resulting data. 11,12 The current study was undertaken in an effort to extend the possible role for IHC in distinguishing between metastatic mammary and primary sudoriferous neoplasms in the skin. The authors included only morphologically malignant lesions that were bona fide microscopic imitators of one another. The immunohistologic markers that were used partially recapitulated the structure of prior publications, but they also included GATA3 gene product. The latter protein has been demonstrated predominantly in tumors of the urothelial tract, breast epithelium, and surface integument. Materials and Methods After obtaining approval from the institutional review board at the University of Virginia, its electronic surgical pathology database was searched between 1990 and 2012 to retrieve examples of MDMC in the skin and SGC. Benign sweat glandular neoplasms, such as syringomas, acrospiromas, spiradenomas, and poromas, were explicitly excluded. Fifty-four cases were ultimately identified, including 33 examples of MDMC and 21 of primary SGC. H&E-stained slides and the clinical records from each case were reviewed to confirm the diagnoses. Archival formalin-fixed, paraffinembedded tissue from the 54 cases was included in a tissue Table 1 Summary of Immunohistochemical Stains and Antigen Retrieval Techniques Antibody Manufacturer Clone Dilution microarray (TMA), which was constructed with four 0.6- mm cores of tumor per case using a manual microarrayer (Beecher Instruments, Sun Prairie, WI). Immunohistochemical analysis was performed of 4-µm thick TMA sections with the DAKO EnVision Plus Dual Link System horseradish peroxidase technique, using commercial antibodies and a DAKO Autostainer Plus (DAKO North America, Carpinteria, CA). Immunostains included GATA3, mammaglobin, p63, CK5/6, and D2-40 Table 1. Nuclear labeling of tumor cells was considered to represent a positive result for GATA3 and p63. Cytoplasmic and/or membranous staining was recorded as a positive result for CK5/6, D2-40, and mammaglobin. Appropriate positive and negative control sections were stained concurrently. Immunolabeling was scored semiquantitatively as follows: 0/negative (<5% of cells stained), 1+ (6%-25% of tumor cells), 2+ (26%-50% of tumor cells), and 3+ (>51% of tumor cells). Staining intensity was also graded as weak, moderate, or strong. Any case with moderate to strong intensity and at least 1+ staining was considered positive. Cases showing weak staining intensity were considered positive only if the staining was in a diffuse pattern (>51% of tumor cells staining). The sensitivity and specificity of each stain, vis-à-vis the diagnoses of primary cutaneous adnexal carcinoma and metastatic breast carcinoma, were calculated using Bayesian methods with a standard 2 2 contingency table. The statistical associations of each stain were analyzed by the Fisher exact test, in which a two-tailed P value of less than.05 was considered statistically significant. Results Demographic Data and Morphologic Composition Antigen Retrieval p63 Biocare (Concord, CA) 4A4 1:200 Citrate, ph 9.0 CK5/6 Biocare CK5/ :100 ph 9.0 GATA3 Biocare L :250 Citrate, ph 6.0 D2-40 Covance D2-40 1:100 None (Princeton, NJ) Mammaglobin Zeta (Sierra Madre, CA) 304-1A5 1:50 None Primary SGCs The study cases were derived from 13 men and 8 women in the SGC cohort, with a mean age of 66.7 years Am J Clin Pathol 2015;143:
3 Mentrikoski and Wick / Adnexal Carcinoma vs Metastatic Breast Carcinoma Table 2 Immunohistochemical Staining Results of p63, CK5/6, D2-40, Mammaglobin, and GATA3 in Primary Sweat Gland Carcinomas and Metastatic Breast Carcinoma Grade of Reactivity, No. (%) Primary Sweat Gland Carcinoma (n = 21) Metastatic Breast Carcinoma to Skin (n = 33) Marker Total Positive Total Positive p63 17 (81) 4 (19) 1 (5) 0 16 (76) 2 (6) 31 (94) 1 (3) 1 (3) 0 CK5/6 15 (71) 6 (29) 0 3 (14) 12 (57) 2 (6) 31 (94) 0 1 (3) 1 (3) D (52) 10 (48) 0 5 (24) 6 (29) 2 (6) 31 (94) 1 (3) 0 1 (3) Mammaglobin 1 (5) 20 (95) 1 (5) (45) 18 (55) 0 1 (3) 14 (42) GATA3 15 (71) 6 (29) 1 (5) 8 (38) 6 (29) 30 (91) 3 (9) 0 3 (9) 27 (82) Table 3 Sensitivity and Specificity, With P Values, for Individual Immunohistochemical Stains Stain p63 CK5/6 D2-40 Mammaglobin GATA3 SGC (n = 21), No. (%) 17 (81) 15 (71) 11 (52) 1 (5) 15 (71) MBCS (n = 33), No. (%) 2 (6) 2 (3) 2 (6) 15 (45) 30 (91) P value <.0001 < Sensitivity, % 81 a 71 a 52 a 45 b 91 b Specificity, % 94 a 94 a 94 a 95 b 29 b a Sensitivity and specificity for the diagnosis of primary sweat gland carcinoma (SGC). b Sensitivity and specificity for the diagnosis of metastatic breast carcinoma to skin (MBCS). (range, years). Of the 21 SGC cases, 19 were classified as eccrine adnexal carcinomas and two as primary cutaneous apocrine adenocarcinomas. Two of the 21 SGC lesions were recurrent tumors; the remaining 19 were primary neoplasms. Primary sites for the SGC cohort included five scalp, four axilla, three chest, two face, two leg, one ear, one abdomen, and one scrotum. When available, the clinical history revealed presence of a lesion for 3 weeks to 5 months (mean, 2.7 months). Metastatic Breast Carcinomas The MDMC group was composed entirely of women with a mean age of 64.3 years (range, years). All examples were associated with a known history of primary breast carcinoma of the ductal type, not further specified prior to diagnosis of metastasis. Thirty cases arose on the skin of the chest ipsilateral to the primary lesion and three in the skin of the ipsilateral axilla. The duration of disease for the MDMC cohort ranged from 1 to 4 weeks from initial presentation of metastatic skin lesion to clinical biopsy/ excision. Immunohistochemical Results Primary Sweat Gland Carcinomas Immunohistochemical staining results in cases of SGC are summarized in Table 2. The sensitivity and specificity of each marker, as well as their P values for the distinction of primary SGC vs MDMC, are listed in Table 3. p63 was expressed most commonly in SGC, with strong, diffuse staining seen in most cases (17/21 [81%]). CK5/6 was also commonly seen in SGCs, whereas podoplanin (D2-40) was detected in a smaller number of SGC cases. All three of these markers were specific for SGC in the specified differential diagnosis (Table 3), but a moderate degree of background staining of dermal collagen was seen in D2-40 preparations Image 1. Among p63, CK5/6, and podoplanin, at least one marker was expressed in 19 (90%) of 21 SGCs, yielding a conjoint sensitivity of 90% and a specificity of 81%. Concurrent labeling for at least two of the three markers increased diagnostic specificity to 100%, but mandating that result for an interpretation of SGC decreased the composite sensitivity of the stains to 71%. Nuclear GATA3 immunoreactivity was apparent in 71% of cases of SGC, with a staining intensity ranging from weak to strong. More heterogeneous intratumoral labeling was observed with GATA3 compared with p63 and CK5/6. Both cases of primary cutaneous apocrine adenocarcinoma were strongly positive for GATA3, but they were negative for all other markers used in this study Image 2. Weak, diffuse cytoplasmic reactivity for mammaglobin was seen in only one example of SGC. Metastatic Breast Carcinomas MDMC rarely stained for p63, CK5/6, or podoplanin, with only two (6%) of 33 cases being labeled for each of those determinants (Image 1). No individual case expressed more than one of the three markers. GATA3 was the most sensitive immunostain for the identification of MDMCs, in which strong, diffuse nuclear positivity was seen in 91%. The specificity of GATA3 for the diagnosis of MDMC was 432 Am J Clin Pathol 2015;143:
4 AJCP / Original Article compromised by its similar expression in 71% of primary SGCs, although labeling of those lesions was more patchy and tended to have at most moderate staining intensity. As an individual marker, mammaglobin was specific (95%) for MDMC, but it lacked sensitivity. Cytoplasmic staining was detected in only 15 (45%) of 33 cases. Both GATA3 and mammaglobin were positive in 42% of cases, with a respective sensitivity and specificity of 42% and 100% for the diagnosis of MDMC. Discussion Although they are relatively uncommon, cutaneous metastases may be seen in up to 10% of all patients with visceral carcinomas.3,14,15 In women, adenocarcinoma of the breast is the most common source for metastasis to the skin, typically presenting with nodular lesions on the trunk, axillae, or chest wall, usually near prior lumpectomy or mastectomy sites.16,17 Many observers still consider the clinical presentation to be of paramount importance in distinguishing MDMC from primary neoplasms of the skin.3,18 Metastatic carcinomas typically manifest with multiple, grouped, rapidly growing lesions, whereas solitary, slowly enlarging (>6 months) lesions are typical of SGC. When adequate clinical information is lacking, immunohistology has been applied to this particular differential diagnosis, with variable success. Over the past decade, several studies have attempted to delineate the optimal panel of markers for the separation of MDMC and SGC.4-13 In general, most of those studies have suffered from a lack of statistical power because of the rarity of primary SGC, with limited numbers of specimens. The current series admittedly has that same limitation. Another issue making the prior literature difficult to interpret is the common inclusion of embryologically related but benign tumors in several studies, potentially causing skewed results.11,12 For instance, although eccrine spiradenomas doubtlessly show sudoriferous differentiation, their morphologic images look nothing like those of metastatic breast carcinomas, and they should not be included in comparative analyses. In this evaluation, we used only primary SGCs that structurally imitated MDMCs. The basal cell markers p63 and CK5/6 were often present in SGCs in our assessment, with p63 being the most sensitive. p63 is a nuclear transcription factor that is involved in keratinocyte differentiation. It is normally expressed in basal epithelial cells, including those of the skin, but is downregulated as the cells mature. In addition to being a marker of squamous differentiation, p63 can be used in breast pathology to highlight myoepithelium surrounding ductal adenocarcinoma in situ; however, it is not Image 1 In a case of metastatic ductal mammary carcinoma (MDMC) (H&E, 10), the tumor cells are negative for p63 and CK5/6. D2-40 highlights stromal cells but is negative in tumor cells. Strong nuclear positivity is seen with GATA3, as is strong cytoplasmic positivity with mammaglobin. In contrast, in a case of primary sweat gland carcinoma (SGC) that arose on the scalp of a 78-year-old woman (H&E, 10), p63 and CK5/6 are strongly positive. Podoplanin is absent in the tumor cells but seen in background stromal cells. GATA3 immunostaining shows diffuse, moderate nuclear positivity. Mammaglobin is lacking. Am J Clin Pathol 2015;143:
5 Mentrikoski and Wick / Adnexal Carcinoma vs Metastatic Breast Carcinoma A B C D Image 2 A case of primary cutaneous apocrine adenocarcinoma in the scalp of a 39-year-old man. Microscopic examination revealed infiltration of the dermis by nests and acini of cells with prominent eosinophilic cytoplasm (A, H&E, 10; B, H&E, 20). Like metastatic breast carcinoma, the tumor cells are strongly positive for GATA3 (C, 40) but negative for p63 (D, 40). usually expressed by invasive mammary carcinomas. Several prior analyses have shown that p63 reactivity generally distinguishes MDMC from SGC,5,6,8,9,11,12 and our study recapitulates that finding. One cautionary note regarding the use of p63 is that it has also been observed in metaplastic mammary carcinomas,19 but the high-grade, sarcomatoid nature of those lesions makes it unlikely that they would enter into differential diagnosis with SGC. CK5/6 is a mixture of cytokeratins that are also considered basal cell markers. Again, previous publications have shown CK5/6 reactivity in most SGCs but not in metastatic adenocarcinomas.10,11 We found that CK5/6 was slightly less sensitive for sweat gland tumors than was p63 (71% vs 81%), but both markers had robust specificity (94%). Although CK5/6 can be expressed in basal-like or 434 Am J Clin Pathol 2015;143: triple-negative breast carcinomas, none of the metastatic cases in our series had that phenotype. D2-40, the antibody that recognizes podoplanin, has classically been used to label lymphatic endothelium. Nonetheless, it has also been detected in a variety of unrelated tumors, including mesotheliomas, seminomas, and primary cutaneous adnexal carcinomas.7 Although Liang and colleagues7 showed variable podoplanin positivity in a spectrum of cutaneous neoplasms other than SGCs, it was nonetheless sensitive and specific for primary lesions of the skin as opposed to metastatic adenocarcinomas. One issue with that particular study was that cellular labeling of only 25% was defined as diffuse, potentially skewing the number of positive cases.7 It is possible that this effect augmented the reported sensitivity of podoplanin in the identification
6 AJCP / Original Article of SGCs, because our series as well as others showed lesser levels of expression in SGC. 8,9 Nevertheless, our results support the premise that podoplanin is a specific marker for SGC and is rarely expressed in MDMC. Unfortunately, because of its limited sensitivity, podoplanin can be considered a thirdline marker for primary skin tumors, behind CK5/6 and p63. As mentioned earlier, a biomarker that is both sensitive and specific for MDMC has yet to be clearly defined. Estrogen and progesterone receptor proteins are often used in surgical pathology as surrogate markers for mammary epithelial differentiation, because most breast carcinomas express those moieties. However, both receptors also may potentially be seen in SGCs, a finding that decreases their usefulness in the specific differential diagnostic setting being considered here. Gross cystic disease fluid protein 15 (GCDFP-15) is another marker of breast carcinoma that has been studied in MDMC. Its comparative lack of sensitivity and specificity, compared with the immunophenotypes of SGCs, has limited the value of GCDFP-15 in this setting. 12,13,21,23 Mammaglobin is another mammary epithelial determinant that is more sensitive but less specific than GCDFP To date, only a single study has evaluated mammaglobin in the differential diagnosis of MDMC and primary SGC. 12 In that series, mammaglobin was observed in two-thirds of MDMCs, whereas it was lacking in all SGCs. Our results showed that mammaglobin had a lower level of sensitivity for MDMC, in line with another publication on primary and metastatic breast carcinomas. 25 GATA3 is a transcription factor that is involved in embryologic development of the mammary glands and urinary bladder, as well as neoplasms in those organs. To our knowledge, GATA3 has not been evaluated in MDMC and SGC. Although it was a sensitive marker for MDMC, it lacked specificity and was also seen in 71% of SGC cases in our series. In context, that is not surprising because other recent publications have shown that GATA3 also participates in the development of the skin. 26,27 Cutaneous apocrine adenocarcinomas are rare sweat gland neoplasms; they most commonly arise in the axilla and anogenital skin. 28 The literature pertaining to these cutaneous tumors is sparse because of their limited frequency, and the current series likewise included only two cases seen over a 20-year period. Apocrine sweat gland carcinomas are essentially indistinguishable from mammary apocrine carcinomas, and those seen in the axillary region are particularly challenging to separate from MDMCs. Interestingly, both tumors in this series occurred in men, with one on the scrotum and the other on the scalp. In summary, primary SGCs are rare neoplasms that can be morphologically comparable to cutaneous metastases from breast carcinomas. Both p63 and CK5/6 were sensitive and specific for the diagnosis of SGC, but a similarly effective breast carcinoma marker has yet to be identified. The clinical setting must continue to play a central role in the appropriate classification of MDMC and SGC. Address reprint requests to Dr Wick: University of Virginia Hospital, 1215 Lee St, Rm 3020, Charlottesville, VA ; mrwick1@usa.net. References 1. Alcaraz I, Cerroni L, Rutten A, et al. Cutaneous metastases from internal malignancies: a clinicopathologic and immunohistochemical review. Am J Dermatopathol. 2012;34: Krathen RA, Orengo IF, Rosen T. Cutaneous metastasis: a meta-analysis of data. South Med J. 2003;96: Lookingbill DP, Spangler N, Sexton FM. Skin involvement as the presenting sign of internal carcinoma: a retrospective study of 7316 cancer patients. J Am Acad Dermatol. 1990;22: Fernandez-Flores A. Podoplanin immunostaining in cutaneous apocrine carcinoma and in cutaneous metastasis from the breast. Appl Immunohistochem Mol Morphol. 2010;18: Ivan D, Hafeez Diwan A, Prieto VG. Expression of p63 in primary cutaneous adnexal neoplasms and adenocarcinoma metastatic to the skin. Mod Pathol. 2005;18: Ivan D, Nash JW, Prieto VG, et al. Use of p63 expression in distinguishing primary and metastatic cutaneous adnexal neoplasms from metastatic adenocarcinoma to skin. J Cutan Pathol. 2007;34: Liang H, Wu H, Giorgadze TA, et al. Podoplanin is a highly sensitive and specific marker to distinguish primary skin adnexal carcinomas from adenocarcinomas metastatic to skin. Am J Surg Pathol. 2007;31: Mahalingam M, Nguyen LP, Richards JE, et al. The diagnostic utility of immunohistochemistry in distinguishing primary skin adnexal carcinomas from metastatic adenocarcinoma to skin: an immunohistochemical reappraisal using cytokeratin 15, nestin, p63, D2-40, and calretinin. Mod Pathol. 2012;23: Plaza JA, Ortega PF, Stockman DL, et al. Value of p63 and podoplanin (D2-40) immunoreactivity in the distinction between primary cutaneous tumors and adenocarcinomas metastatic to the skin: a clinicopathologic and immunohistochemical study of 79 cases. J Cutan Pathol. 2010;37: Plumb SJ, Argenyi ZB, Stone MS, et al. Cytokeratin 5/6 immunostaining in cutaneous adnexal neoplasms and metastatic adenocarcinoma. Am J Dermatopathol. 2004;26: Qureshi HS, Ormsby AH, Lee MW, et al. The diagnostic utility of p63, CK5/6, CK 7, and CK 20 in distinguishing primary cutaneous adnexal neoplasms from metastatic carcinomas. J Cutan Pathol. 2004;31: Rollins-Raval M, Chivukula M, Tseng GC, et al. An immunohistochemical panel to differentiate metastatic breast carcinoma to skin from primary sweat gland carcinomas with a review of the literature. Arch Pathol Lab Med. 2012;135: Am J Clin Pathol 2015;143:
7 Mentrikoski and Wick / Adnexal Carcinoma vs Metastatic Breast Carcinoma 13. Wick MR, Ockner DM, Mills SE, et al. Homologous carcinomas of the breasts, skin, and salivary glands: a histologic and immunohistochemical comparison of ductal mammary carcinoma, ductal sweat gland carcinoma, and salivary duct carcinoma. Am J Clin Pathol. 1998;109: Lookingbill DP, Spangler N, Helm KF. Cutaneous metastases in patients with metastatic carcinoma: a retrospective study of 4020 patients. J Am Acad Dermatol. 1993;29: Schwartz RA. Cutaneous metastatic disease. J Am Acad Dermatol. 1995;33: De Giorgi V, Grazzini M, Alfaioli B, et al. Cutaneous manifestations of breast carcinoma. Dermatol Ther. 2010;23: Pipkin CA, Lio PA. Cutaneous manifestations of internal malignancies: an overview. Dermatol Clin. 2008;26:1-15, vii. 18. Brownstein MH, Helwig EB. Patterns of cutaneous metastasis. Arch Dermatol. 1972;105: Koker MM, Kleer CG. p63 expression in breast cancer: a highly sensitive and specific marker of metaplastic carcinoma. Am J Surg Pathol. 2004;28: Swanson PE, Mazoujian G, Mills SE, et al. Immunoreactivity for estrogen receptor protein in sweat gland tumors. Am J Surg Pathol. 1991;15: Wallace ML, Longacre TA, Smoller BR. Estrogen and progesterone receptors and anti gross cystic disease fluid protein 15 (BRST-2) fail to distinguish metastatic breast carcinoma from eccrine neoplasms. Mod Pathol. 1995;8: Kariya Y, Moriya T, Suzuki T, et al. Sex steroid hormone receptors in human skin appendage and its neoplasms. Endocr J. 2005;52: Wallace ML, Smoller BR. Differential sensitivity of estrogen/ progesterone receptors and BRST-2 markers in metastatic ductal and lobular breast carcinoma to the skin. Am J Dermatopathol. 1996;18: Bhargava R, Beriwal S, Dabbs DJ. Mammaglobin vs GCDFP- 15: an immunohistologic validation survey for sensitivity and specificity. Am J Clin Pathol. 2007;127: Luo MH, Huang YH, Ni YB, et al. Expression of mammaglobin and gross cystic disease fluid protein-15 in breast carcinomas. Hum Pathol. 2013;44: Kaufman CK, Zhou P, Pasolli HA, et al. GATA-3: an unexpected regulator of cell lineage determination in skin. Genes Dev. 2003;17: Sellheyer K, Krahl D. Expression pattern of GATA-3 in embryonic and fetal human skin suggests a role in epidermal and follicular morphogenesis. J Cutan Pathol. 2010;37: Robson A, Lazar AJ, Ben Nagi J, et al. Primary cutaneous apocrine carcinoma: a clinico-pathologic analysis of 24 cases. Am J Surg Pathol. 2008;32: Am J Clin Pathol 2015;143:
BSD 2015 Case 19. Female 21. Nodule on forehead. The best diagnosis is:
BSD 2015 Case 19 Female 21. Nodule on forehead. The best diagnosis is: A. mixed tumour of skin B. porocarcinoma C. nodular hidradenoma D. metastatic adenocarcinoma BSD 2015 Case 19 Female 21 Nodule on
More informationCase 18. M75. Excision of mass on scalp. Clinically SCC. The best diagnosis is:
Case 18 M75. Excision of mass on scalp. Clinically SCC. The best diagnosis is: A. Pilomatrical carcinoma B. Adnexal carcinoma NOS C. Metastatic squamous cell carcinoma D.Primary squamous cell carcinoma
More informationconfusing, especially in small, limited biopsies. One such case of digital papillary adnexal adenocarcinoma with unusual histologic features will be
1 Cutaneous Adnexal Lesions: The Must-Know Stuff 2011 USCAP Annual Meeting Dermatopathology Companion Meeting Doina Ivan, M.D. University of Texas MD Anderson Medical Center, Houston, TX The diagnosis
More informationResearch Article A Clinicopathological and Immunohistochemical Correlation in Cutaneous Metastases from Internal Malignancies: A Five-Year Study
Skin Cancer, Article ID 793937, 5 pages http://dx.doi.org/10.1155/2014/793937 Research Article A Clinicopathological and Immunohistochemical Correlation in Cutaneous Metastases from Internal Malignancies:
More informationCluster designation 5 staining of normal and non-lymphoid neoplastic skin*
J Cutan Pathol 2005: 32: 50 54 Copyright # Blackwell Munksgaard 2005 Blackwell Munksgaard. Printed in Denmark Journal of Cutaneous Pathology Cluster designation 5 staining of normal and non-lymphoid neoplastic
More informationPapillary Lesions of the Breast A Practical Approach to Diagnosis. (Arch Pathol Lab Med. 2016;140: ; doi: /arpa.
Papillary Lesions of the Breast A Practical Approach to Diagnosis (Arch Pathol Lab Med. 2016;140:1052 1059; doi: 10.5858/arpa.2016-0219-RA) Papillary lesions of the breast Span the spectrum of benign,
More informationWhitney A. High, MD, JD, MEng
ADS Dermatopathology Meeting 2014 Selected Adnexal Tumors Whitney A. High, MD, JD, MEng Associate Professor, Dermatology & Pathology Director of Dermatopathology (Dermatology) University of Colorado School
More informationCoordinate Expression of Cytokeratins 7 and 20 in Prostate Adenocarcinoma and Bladder Urothelial Carcinoma
Anatomic Pathology / CYTOKERATINS 7 AND 20 IN PROSTATE AND BLADDER CARCINOMAS Coordinate Expression of Cytokeratins 7 and 20 in Prostate Adenocarcinoma and Bladder Urothelial Carcinoma Nader H. Bassily,
More informationBreast cancer: IHC classification. Mogens Vyberg Professor of Clinical Pathology Director of NordiQC Aalborg University Hospital, Aalborg, Denmark
Breast cancer: IHC classification Mogens Vyberg Professor of Clinical Pathology Director of NordiQC Aalborg University Hospital, Aalborg, Denmark http://upload.wikimedia.org/wikipedia/commons/1/1a/breast.svg
More information1 NORMAL HISTOLOGY AND METAPLASIAS
1 NORMAL HISTOLOGY AND METAPLASIAS, MD Anatomy and Histology 1 Metaplasias 2 ANATOMY AND HISTOLOGY The female breast is composed of a branching duct system, which begins at the nipple with the major lactiferous
More informationEnterprise Interest None
Enterprise Interest None B3 lesions of the breast What are they at surgery? Case 4 Edi Brogi MD PhD Attending Pathologist - Director of Breast Pathology Memorial Sloan Kettering Cancer Center New York
More informationAcantholytic Anaplastic Extramammary Paget s Disease: A Case Report and Review of the Literature
Ann Dermatol Vol. 23, Suppl. 2, 2011 http://dx.doi.org/10.5021/ad.2011.23.s2.s226 CASE REPORT Acantholytic Anaplastic Extramammary Paget s Disease: A Case Report and Review of the Literature Yu-Jin Oh,
More informationSlide seminar. Asist. Prof. Jože Pižem, MD, PhD Institute of Pathology Medical Faculty, University of Ljubljana
Slide seminar Asist. Prof. Jože Pižem, MD, PhD Institute of Pathology Medical Faculty, University of Ljubljana Case 5 A 57-year-old man with a dermal/subcutaneous lesion on the scalp, which was interpreted
More informationUniversity Journal of Pre and Para Clinical Sciences
ISSN 2455 2879 Volume 2 Issue 1 2016 Metaplastic carcinoma breast a rare case report Abstract : Metaplastic carcinoma of the breast is a rare malignancy with two distinct cell lines described as a breast
More informationIntroduction. Results. Discussion. Histopathologic and immunohistochemical findings. Results. conclusions,
1/5 2/5 Carcinoma distinctive carcinoma. form erysipeloides (CE), metastasis. which clinically Itfrom has resembles been termed erysipelas, is an uncommon, but may extend It164 toclassically back, presents
More informationCase history: Figure 1. H&E, 5x. Figure 2. H&E, 20x.
1 Case history: A 49 year-old female presented with a 5 year history of chronic anal fissure. The patient s past medical history is otherwise unremarkable. On digital rectal examination there was a very
More informationWhat I Learned from 3 Cases and 3 Antibodies
What I Learned from 3 Cases and 3 Antibodies Melinda Sanders, M.D Vanderbilt University Medical Center Professor of Pathology Consultant in Breast Pathology Disclosure of Relevant Financial Relationships
More informationCutaneous metastases. Thaddeus Mully. University of California, San Francisco Professor, Departments of Pathology and Dermatology
Cutaneous metastases Thaddeus Mully University of California, San Francisco Professor, Departments of Pathology and Dermatology DISCLOSURE OF RELATIONSHIPS WITH INDUSTRY Thaddeus Mully Course C005 Essential
More informationMammaglobin vs GCDFP-15 An Immunohistologic Validation Survey for Sensitivity and Specificity
Anatomic Pathology / MAMMAGLOBIN IN BREAST CARCINOMA Mammaglobin vs GCDFP-15 An Immunohistologic Validation Survey for Sensitivity and Specificity Rohit Bhargava, MD, 1 Sushil Beriwal, MD, 2 and David
More informationGATA3: A Promising Marker for Metastatic Breast Carcinoma in Serous Effusion Specimens
GATA3: A Promising Marker for Metastatic Breast Carcinoma in Serous Effusion Specimens Paul W. Shield, PhD, FFSc(RCPA) 1,2 ; David J. Papadimos, MBBS, FRCPA 1,3 ; and Michael D. Walsh, PhD 3 BACKGROUND:
More informationCME. CK5 Is More Sensitive Than CK5/6 in Identifying the Basal-like Phenotype of Breast Carcinoma
Anatomic Pathology / CK5 vs CK5/6 in Breast Carcinoma CK5 Is More Sensitive Than CK5/6 in Identifying the Basal-like Phenotype of Breast Carcinoma Rohit Bhargava, MD, 1 Sushil Beriwal, MD, 2 Kim McManus,
More informationBASAL CELL CARCINOMA WITH ECCRINE DIFFERENTIATION: A RARE ENTITY Divvya B 1, Rehana Tippoo 2, P. Viswanathan 3, B. Krishnaswamy 4, A.
BASAL CELL CARCINOMA WITH ECCRINE DIFFERENTIATION: A RARE ENTITY Divvya B 1, Rehana Tippoo 2, P. Viswanathan 3, B. Krishnaswamy 4, A. Anvar Ali 5 HOW TO CITE THIS ARTICLE: Divvya B, Rehana Tippoo, P. Viswanathan,
More informationCancers of unknown primary : Knowing the unknown. Prof. Ahmed Hossain Professor of Medicine SSMC
Cancers of unknown primary : Knowing the unknown Prof. Ahmed Hossain Professor of Medicine SSMC Definition Cancers of unknown primary site (CUPs) Represent a heterogeneous group of metastatic tumours,
More informationApocrine and eccrine adnexal tumors
Apocrine and eccrine adnexal tumors Timothy McCalmont, MD University of California San Francisco, CA ECCRINE TUMORS Generally uncommon, because the sweat apparatus has little proliferative potential (hyperproliferation
More information57th Annual HSCP Spring Symposium 4/16/2016
An Unusual Malignant Spindle Cell Lesion to Involve the Breast Erinn Downs-Kelly, D.O. Associate Professor of Pathology University of Utah & ARUP Laboratories No disclosures Case 39 y/o female with no
More informationUpdate in Salivary Gland Pathology. Benjamin L. Witt University of Utah/ARUP Laboratories February 9, 2016
Update in Salivary Gland Pathology Benjamin L. Witt University of Utah/ARUP Laboratories February 9, 2016 Objectives Review the different appearances of a selection of salivary gland tumor types Establish
More informationACCME/Disclosures. Diagnosing Mesothelioma in Limited Tissue Samples. Papanicolaou Society of Cytopathology Companion Meeting March 12 th, 2016
Diagnosing Mesothelioma in Limited Tissue Samples Papanicolaou Society of Cytopathology Companion Meeting March 12 th, 2016 Sanja Dacic, MD, PhD University of Pittsburgh ACCME/Disclosures GENERAL RULES
More information- Selected Tumors of the Skin Appendages - Primary vs. Metastasis
- Selected Tumors of the Skin Appendages - Primary vs. Metastasis Napa Valley 2018 Victor G. Prieto, MD, PhD Chair of Pathology UT MD Anderson Cancer Center vprieto@mdanderson.org Napa Valley in May Introduction
More informationAdnexal primary or Melanocy+c prolifera+ons in sundamaged metastatic carcinoma?
Adnexal primary or Melanocy+c prolifera+ons in sundamaged metastatic carcinoma? skin Jane L. Messina, MD Interna0onal Melanoma Pathology Working Group 4 th annual mee0ng Tampa, Florida November 14, 2011
More informationQuality Assurance and Quality Control in the Pathology Dept.
Quality Assurance and Quality Control in the Pathology Dept. Judith Sandbank M.D. Pathology Assaf-Harofeh Medical Center ISRAEL jsandbank@asaf.health.gov.il 2 nd IBDC, 9 th February, 2012 Pathology as
More informationDisclosure. Relevant Financial Relationship(s) None. Off Label Usage None MFMER slide-1
Disclosure Relevant Financial Relationship(s) None Off Label Usage None 2013 MFMER slide-1 Case Presentation A 43 year old male, with partial nephrectomy for a right kidney mass 2013 MFMER slide-2 2013
More informationApocrine and eccrine adnexal tumors
Apocrine and eccrine adnexal tumors Timothy McCalmont, MD University of California San Francisco, CA Past misguided notions Syringoma is eccrine Eccrine poroma rather than eccrine or apocrine poroma Spiradenoma
More informationGross appearance of nodular hyperplasia in material obtained from suprapubic prostatectomy. Note the multinodular appearance and the admixture of
Tiền liệt tuyến Tiền liệt tuyến Gross appearance of nodular hyperplasia in material obtained from suprapubic prostatectomy. Note the multinodular appearance and the admixture of solid and microcystic areas.
More informationImmunohistochemical Expression of Hormone Receptors and The Histological Characteristics of Biochemically Hormone Receptor Negative Breast Cancers
Breast Cancer Vol. 14 No. 1 January 2007 Original Article Immunohistochemical Expression of Hormone Receptors and The Histological Characteristics of Biochemically Hormone Receptor Negative Breast Cancers
More informationSynonyms. Nephrogenic metaplasia Mesonephric adenoma
Nephrogenic Adenoma Synonyms Nephrogenic metaplasia Mesonephric adenoma Definition Benign epithelial lesion of urinary tract with tubular, glandular, papillary growth pattern Most frequently in the urinary
More informationFORELIMB SWEAT GLAND ADENOCARCINOMA IN A CAT
I: 2047-2051 ISSN: 2277 4998 FORELIMB SWEAT GLAND ADENOCARCINOMA IN A CAT ABEDI G 1, HESARAKI S 2, ASGHARI A 1* 1: Department of Clinical Science, Science and Research branch, Islamic Azad University,
More informationWhen Immunostains Can Get You in Trouble: Gynecologic Pathology p16: Panacea or Pandora s Box?
When Immunostains Can Get You in Trouble: Gynecologic Pathology p16: Panacea or Pandora s Box? Teri A. Longacre, MD Stanford Medicine Stanford California pi6 in Gynecologic Pathology: Panacea or Pandora
More informationWT1, Estrogen Receptor, and Progesterone Receptor as Markers for Breast or Ovarian Primary Sites in Metastatic Adenocarcinoma to Body Fluids
Anatomic Pathology / WT1, ESTROGEN RECEPTOR, AND PROGESTERONE RECEPTOR IN CYTOLOGY OF BODY FLUIDS WT1, Estrogen Receptor, and Progesterone Receptor as Markers for Breast or Ovarian Primary Sites in Metastatic
More informationCutaneous Adnexal Tumors
Cutaneous Adnexal Tumors Lesions with Predominant Follicular Differentiation Special Emphasis on Basal Cell Carcinoma 2014-04-01 Prof. Dr. med. Katharina Glatz Pathologie Cutaneous Adnexal Tumors Hair
More informationJournal of International Academy of Forensic Science & Pathology (JIAFP)
Journal of International Academy of Forensic Science & Pathology (JIAFP) ISSN 2395-0722 MICROCYSTIC ADNEXAL CARCINOMA-A CASE REPORT WITH REVIEW OF LITERATURE Case Report Sulakshana M S 1,Natarajan M 2
More informationDiseases of the breast (1 of 2)
Diseases of the breast (1 of 2) Introduction A histology introduction Normal ducts and lobules of the breast are lined by two layers of cells a layer of luminal cells overlying a second layer of myoepithelial
More informationRecent advances in breast cancers
Recent advances in breast cancers Breast cancer is a hetrogenous disease due to distinct genetic alterations. Similar morphological subtypes show variation in clinical behaviour especially in response
More informationPathology Mystery and Surprise
Pathology Mystery and Surprise Tim Smith, MD Director Anatomic Pathology Medical University of South Carolina Disclosures No conflicts to declare Some problem cases Kidney tumor Scalp tumor Bladder tumor
More information3/27/2017. Pulmonary Pathology Specialty Conference. Disclosure of Relevant Financial Relationships. Clinical History:
Pulmonary Pathology Specialty Conference Saul Suster, M.D. Medical College of Wisconsin Disclosure of Relevant Financial Relationships USCAP requires that all planners (Education Committee) in a position
More informationACCME/Disclosures. Case History 4/13/2016. USCAP GU Specialty Conference Case 3. Ann Arbor, MI
USCAP GU Specialty Conference Case 3 March 2016 L. Priya Kunju, M.D. University of Michigan Health System Ann Arbor, MI University of Michigan Health System ACCME/Disclosures The USCAP requires that anyone
More informationApocrine Hidradenocarcinoma of the Scalp: A Classification Conundrum
Head and Neck Pathol (2009) 3:42 46 DOI 10.1007/s12105-008-0096-8 CASE REPORT Apocrine Hidradenocarcinoma of the Scalp: A Classification Conundrum Marc Cohen Æ David S. Cassarino Æ Hubert B. Shih Æ Elliot
More informationRegressive Change in High-Grade Ductal Carcinoma In Situ of the Breast. Jason K. Wasserman, MD, PhD, and Carlos Parra-Herran, MD, FCAP
AJCP / Original Article Regressive Change in High-Grade Ductal Carcinoma In Situ of the Breast Histopathologic Spectrum and Biologic Importance Jason K. Wasserman, MD, PhD, and Carlos Parra-Herran, MD,
More informationSynchronous squamous cell carcinoma of the breast. and invasive lobular carcinoma
Sentani K et al. 1 Letter to the editor Synchronous squamous cell carcinoma of the breast and invasive lobular carcinoma Kazuhiro Sentani, 1 Takashi Tashiro, 2 Naohide Oue, 1 Wataru Yasui 1 1 Department
More informationEstrogen receptor (ER)
Material The slide to be stained for ER comprised: Assessment Run B26 2018 Estrogen receptor (ER) No. Tissue ER-positivity* ER-intensity* 1. Uterine cervix 80-90% Moderate to strong 2. Tonsil 1-5% Weak
More informationDiplomate of the American Board of Pathology in Anatomic and Clinical Pathology
A 33-year-old male with a left lower leg mass. Contributed by Shaoxiong Chen, MD, PhD Assistant Professor Indiana University School of Medicine/ IU Health Partners Department of Pathology and Laboratory
More informationARTHUR PURDY STOUT SOCIETY COMPANION MEETING: DIFFICULT NEW DIFFERENTIAL DIAGNOSES IN PROSTATE PATHOLOGY. Jonathan I. Epstein.
1 ARTHUR PURDY STOUT SOCIETY COMPANION MEETING: DIFFICULT NEW DIFFERENTIAL DIAGNOSES IN PROSTATE PATHOLOGY Jonathan I. Epstein Professor Pathology, Urology, Oncology The Reinhard Professor of Urological
More information# Best Practices for IHC Detection and Interpretation of ER, PR, and HER2 Protein Overexpression in Breast Cancer
#1034 - Best Practices for IHC Detection and Interpretation of ER, PR, and HER2 Protein Overexpression in Breast Cancer Richard W. Cartun, MS, PhD Andrew Ricci, Jr, MD Department of Pathology Hartford
More informationOptimization of antibodies, selection, protocols and controls Breast tumours
Optimization of antibodies, selection, protocols and controls Breast tumours Søren Nielsen Project coordinator & Scheme Manager NordiQC Aalborg University Hospital, Denmark Breast panel: GCDFP-15 Mammaglobin
More informationEstrogen receptor (ER)
Material The slide to be stained for ER comprised: Assessment B25 208 Estrogen receptor (ER) No. Tissue ER-positivity* ER-intensity*. Uterine cervix 80-90% Moderate to strong 2. Tonsil < 2-5% Weak to strong
More informationUrinary Bladder: WHO Classification and AJCC Staging Update 2017
Urinary Bladder: WHO Classification and AJCC Staging Update 2017 Houston Society of Clinical Pathologists 58 th Annual Spring Symposium Houston, TX April 8, 2017 Jesse K. McKenney, MD Classification
More informationTriple Negative Breast Cancer
Triple Negative Breast Cancer Prof. Dr. Pornchai O-charoenrat Division of Head-Neck & Breast Surgery Department of Surgery Faculty of Medicine Siriraj Hospital Breast Cancer Classification Traditional
More informationDIAGNOSTIC SLIDE SEMINAR: PART 1 RENAL TUMOUR BIOPSY CASES
DIAGNOSTIC SLIDE SEMINAR: PART 1 RENAL TUMOUR BIOPSY CASES Dr. Andrew J. Evans MD, PhD, FACP, FRCPC Consultant in Genitourinary Pathology University Health Network, Toronto, ON Case 1 43 year-old female,
More informationBAP-oma & BEYOND MICHAEL A NOWAK, MD
BAP-oma & BEYOND MICHAEL A NOWAK, MD CONFLICTS No conflicts with the content of this lecture BAP-oma Wiesner 2011: Families with multiple tan dome-shaped papules of head, neck, trunk, and extremities.
More informationBreast Pathology. Breast Development
Breast Pathology Lecturer: Hanina Hibshoosh, M.D. Reading: Kumar, Cotran, Robbins, Basic Pathology, 6th Edition, pages 623-635 Breast Development 5th week - thickening of the epidermis - milk line 5th
More informationACCME/Disclosures. Cribriform Lesions of the Prostate. Case
Cribriform Lesions of the Prostate Ming Zhou, MD, PhD Departments of Pathology and Urology New York University Langone Medical Center New York, NY Ming.Zhou@NYUMC.ORG ACCME/Disclosures The USCAP requires
More informationProstate Immunohistochemistry. Literature Interpretation: Caveats. Must be aware of staining pattern of antibody in the relevant tissue
IHC Interpretation: General Principles (1) Prostate Immunohistochemistry Murali Varma Cardiff, UK wptmv@cf.ac.uk Sarajevo Nov 2013 Must be aware of staining pattern of antibody in the relevant tissue Nuclear/cytoplasmic/membranous
More informationDuctal Proliferations of the Breast: The Good, the Bad, and the Ugly
Ductal Proliferations of the Breast: The Good, the Bad, and the Ugly Melinda F. Lerwill, MD CRITERIA FOR DISTINGUISHING LOW-GRADE DUCTAL CARCINOMA IN SITU FROM USUAL DUCTAL HYPERPLASIA CYTOLOGY Low-grade
More informationAssessment Run GATA3
Assessment Run 44 2015 GATA3 Material The slide to be stained for GATA3 comprised: 1. Tonsil 2. Kidney, 3. Urothelial carcinoma, 4. Breast ductal carcinoma, 5. Colon adenocarcinoma All tissues were fixed
More informationDiagnostic accuracy of percutaneous renal tumor biopsy May 10 th 2018
Diagnostic accuracy of percutaneous renal tumor biopsy May 10 th 2018 Dr. Tzahi Neuman Dep.Of Pathology Hadassah Medical Center Jerusalem, Israel, (tneuman@hadassah.org.il) Disclosure: 1 no conflicts of
More informationCase Report Aggressive invasive micropapillary salivary duct carcinoma of the parotid gland
Pathology International 2008; 58: 322 326 doi:10.1111/j.1440-1827.2008.02231.x Case Report Aggressive invasive micropapillary salivary duct carcinoma of the parotid gland Hidetaka Yamamoto, 1 Hideoki Uryu,
More informationDIAGNOSTIC DILEMMA. Case Reports Clinical history. Materials and Methods
DIAGNOSTIC DILEMMA A Metastatic Renal Carcinoid Tumor Presenting as Breast Mass: A Diagnostic Dilemma Farnaz Hasteh, M.D., 1 Robert Pu, M.D., Ph.D., 2 and Claire W. Michael, M.D. 2 * We present clinicopathological
More informationEnterprise Interest Nothing to declare
Enterprise Interest Nothing to declare Diagnoses one would not like to miss in soft tissue pathology early in your career Marta Sbaraglia, MD Department of Pathology Hospital of Treviso University of Padua
More informationNeuroendocrine differentiation in pure type mammary mucinous carcinoma is associated with favorable histologic and immunohistochemical parameters
& 2004 USCAP, Inc All rights reserved 0893-3952/04 $25.00 www.modernpathology.org Neuroendocrine differentiation in pure type mammary mucinous carcinoma is associated with favorable histologic and immunohistochemical
More informationInterpretation of Breast Pathology in the Era of Minimally Invasive Procedures
Shahla Masood, M.D. Professor and Chair Department of Pathology and Laboratory Medicine University of Florida College of Medicine Jacksonville Medical Director, UF Health Breast Center Chief of Pathology
More informationCASE REPORT SOLITARY SEBACEOUS NEVUS OF JADASSOHN COMPLICATED BY SQUAMOUS CELL CARCINOMA AND BASAL CELL CARCINOMA
CASE REPORT Dennis H. Kraus, MD, Section Editor SOLITARY SEBACEOUS NEVUS OF JADASSOHN COMPLICATED BY SQUAMOUS CELL CARCINOMA AND BASAL CELL CARCINOMA Ahmad Ridzwan Arshad, FRCS, 1 Wan S. Azman, MS, 1 Ayadurai
More informationUniversity of Zurich. Histology and Immunophenotype of Invasive Lobular Breast Cancer. Daily Practice and Pitfalls. Zurich Open Repository and Archive
University of Zurich Zurich Open Repository and Archive Winterthurerstr. 190 CH-8057 Zurich http://www.zora.uzh.ch Year: 2009 Histology and Immunophenotype of Invasive Lobular Breast Cancer. Daily Practice
More informationPruritus Ani in an Elderly Man
Pruritus Ani in an Elderly Man Pedro Redondo, MD; Michel Idoate, MD; Agustín España, MD; Emilio Quintanilla, MD; University of Navarra, Pamplona, Spain REPORT OF A CASE A 78-year-old man presented with
More informationMammary analogue secretory carcinoma of salivary gland A case report of new entity
Case Report Mammary analogue secretory carcinoma of salivary gland A case report of new entity Vaibhav Bhika Bari 1*, Sandhya Unmesh Bholay 2 1 Assistant Professor, 2 Associate Professor Rajiv Gandhi Medical
More informationObjectives. Salivary Gland FNA: The Milan System. Role of Salivary Gland FNA 04/26/2018
Salivary Gland FNA: The Milan System Dr. Jennifer Brainard Section Head Cytopathology Cleveland Clinic Objectives Introduce the Milan System for reporting salivary gland cytopathology Define cytologic
More informationDisclosure of Relevant Financial Relationships
Squamous entities of the thyroid: Reactive to Neoplastic Michelle D. Williams Associate Professor Dept of Pathology, Head & Neck Section University of Texas MD Anderson Cancer Center Disclosure of Relevant
More informationEvening Specialty Conference: Cytopathology
: Cytopathology N. Paul Ohori, M.D. University of Pittsburgh Medical Center Disclosure of Relevant Financial Relationships Disclosure of Relevant Financial Relationships USCAP requires that all planners
More informationPrimary Cutaneous Apocrine Carcinoma of Sweat Glands: A Rare Case Report
This is an Open Access article licensed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs 3.0 License (www.karger.com/oa-license), applicable to the online version of the article
More informationMesothelioma: diagnostic challenges from a pathological perspective. Naseema Vorajee August 2016
Mesothelioma: diagnostic challenges from a pathological perspective Naseema Vorajee August 2016 Naseema.vorajee@nhls.ac.za Pleural diseases (whether neoplastic, reactive or infective) may have similar
More information4/12/2018. MUSC Pathology Symposium Kiawah Island April 18, Jesse K. McKenney, MD
MUSC Pathology Symposium Kiawah Island April 18, 2018 Jesse K. McKenney, MD 1 Urothelial Carcinoma with Alternative Differentiation 2 Urothelial Carcinoma with Alternative Differentiation Recognition as
More informationSkin Adnexal Tumors - A Histopathological Spectrum at a Tertiary Care Hospital
Original Article GCSMC J Med Sci Vol (VI) No (I) January-June 2017 Skin Adnexal Tumors - A Histopathological Spectrum at a Tertiary Care Hospital Neeraja Barve*, Hansa Goswami**, Urvi Parikh *** Abstract
More informationBasement membrane in lobule.
Bahram Memar, MD Basement membrane in lobule. Normal lobule-luteal phase Normal lobule-follicular phase Lactating breast Greater than 95% are adenocarcinomas in situ carcinomas and invasive carcinomas.
More informationNote: The cause of testicular neoplasms remains unknown
- In the 15- to 34-year-old age group, they are the most common tumors of men. - Tumors of the testis are a heterogeneous group of neoplasms that include: I. Germ cell tumors : 95%; all are malignant.
More informationThe Panel Approach to Diagnostics. Lauren Hopson International Product Specialist Cell Marque Corporation
The Panel Approach to Diagnostics Lauren Hopson International Product Specialist Cell Marque Corporation Cell Marque Rocklin, California About Cell Marque: IVD primary antibody manufacturer Distributors
More informationBiopsy Interpretation of Spindle cell proliferations of the Serosa
Biopsy Interpretation of Spindle cell proliferations of the Serosa Richard Attanoos, Cardiff. U.K. Disclosure of Relevant Financial Relationships USCAP requires that all planners (Education Committee)
More informationInternational Journal of Health Sciences and Research ISSN:
International Journal of Health Sciences and Research www.ijhsr.org ISSN: 2249-9571 Original Research Article A Clinicopathological Study of Adnexal Tumors of Skin in a Tertiary Care Research Hospital
More informationSolid Cystic Hidradenoma: A Case Report
IOSR Journal of Dental and Medical Sciences (IOSR-JDMS) e-issn: 2279-0853, p-issn: 2279-0861.Volume 14, Issue 8 Ver. VII (Aug. 2015), PP 32-36 www.iosrjournals.org Solid Cystic Hidradenoma: A Case Report
More informationCME. False-Positive Sentinel Lymph Nodes in Breast Cancer Patients Caused by Benign Glandular Inclusions
Anatomic Pathology / Glandular Inclusions in Sentinel Nodes False-Positive Sentinel Lymph Nodes in Breast Cancer Patients Caused by Benign Glandular Inclusions Report of Three Cases and Review of the Literature
More informationEccrine Differentiation in Basal Cell Carcinoma
295S Eccrine Differentiation in Basal Cell Carcinoma Peter J. Heenan and Matthew S. Bogle Eccrine differentiation according to histologic and immuno-histochemical criteria was demonstrated in 16 of 66
More informationOncocytic-Appearing Salivary Gland Tumors. Oncocytic, Cystic, Mucinous, and High Grade Salivary Gland Tumors SALIVARY GLAND FNA: PART II
William C. Faquin, MD, PhD Professor of Pathology Harvard Medical School Director of Head and Neck Pathology Massachusetts Eye and Ear Massachusetts General Hospital SALIVARY GLAND FNA: PART II Oncocytic,
More informationInvasive Papillary Breast Carcinoma
410 This is an Open Access article licensed under the terms of the Creative Commons Attribution- NonCommercial-NoDerivs 3.0 License (www.karger.com/oa-license), applicable to the online version of the
More informationDisorders of Cell Growth & Neoplasia. Histopathology Lab
Disorders of Cell Growth & Neoplasia Histopathology Lab Paul Hanna April 2010 Case #84 Clinical History: 5 yr-old, West Highland White terrier. skin mass from axillary region. has been present for the
More informationCase Report A case of matrix-producing carcinoma of the breast with micoglandular adenosis and review of literature
Int J Clin Exp Pathol 2015;8(7):8568-8572 www.ijcep.com /ISSN:1936-2625/IJCEP0010093 Case Report A case of matrix-producing carcinoma of the breast with micoglandular adenosis and review of literature
More informationCASE 4 21/07/2017. Ectopic Prostatic Tissue in Cervix. Female 31. LLETZ for borderline nuclear abnormalities
Female 31 CASE 4 LLETZ for borderline nuclear abnormalities PSA Ectopic Prostatic Tissue in Cervix AJSP 2006;30;209-215 usually incidental microscopic finding usually in ectocervical stroma? developmental
More informationProliferative Breast Disease: implications of core biopsy diagnosis. Proliferative Breast Disease
Proliferative Breast Disease: implications of core biopsy diagnosis Jean F. Simpson, M.D. Breast Pathology Consultants, Inc. Nashville, TN Proliferative Breast Disease Must be interpreted in clinical and
More informationGlycogen-rich adenocarcinoma in the lower lip: report of a case with particular emphasis on differential diagnosis
Open Journal of Stomatology, 2011, 1, 109-113 doi:10.4236/ojst.2011.13017 Published Online September 2011 (http://www.scirp.org/journal//). Glycogen-rich adenocarcinoma in the lower lip: report of a case
More informationCASE REPORT Malignant transformation of breast ductal adenoma: a diagnostic pitfall
Malaysian J Pathol 2015; 37(3) : 281 285 CASE REPORT Malignant transformation of breast ductal adenoma: a diagnostic pitfall Hiroko HAYASHI, Hiroshi OHTANI,* Junzo YAMAGUCHI,** and Isao SHIMOKAWA Department
More informationImmunohistochemical Expression Of Cytokeratin 8 And 18 In Breast Carcinoma.
ISPUB.COM The Internet Journal of Pathology Volume 13 Number 3 Immunohistochemical Expression Of Cytokeratin 8 And 18 In Breast Carcinoma. B Rattan, A Baghla, M Manjari, P Kakkar, S Kahlon, S Paul Citation
More informationReview and Updates of Immunohistochemistry in Selected Salivary Gland and Head and Neck Tumors
Review and Updates of Immunohistochemistry in Selected Salivary Gland and Head and Neck Tumors. Monophasic tumors : myoepithelioma, acinic cell carcinoma, and salivary duct carcinoma. Biphasic tumors includes
More informationCase Report A Rare Cutaneous Adnexal Tumor: Malignant Proliferating Trichilemmal Tumor
Case Reports in Medicine Volume 2015, Article ID 742920, 4 pages http://dx.doi.org/10.1155/2015/742920 Case Report A Rare Cutaneous Adnexal Tumor: Malignant Proliferating Trichilemmal Tumor Omer Alici,
More information